(Q36055008)

11 August 2017

Effect of caffeine on clozapine pharmacokinetics in healthy volunteers (English)

1 reference

11 August 2017

1 reference

2

Spigset O

1 reference

11 August 2017

Hägg S

1

1 reference

11 August 2017

Mjörndal T

series ordinal

3

1 reference

11 August 2017

Dahlqvist R

series ordinal

4

1 reference

11 August 2017

language of work or name

English

0 references

publication date

1 January 2000

1 reference

British Journal of Clinical Pharmacology

11 August 2017

1 reference

11 August 2017

49

1 reference

11 August 2017

1

1 reference

11 August 2017

59-63

1 reference

Population pharmacokinetics of clozapine evaluated with the nonparametric maximum likelihood method

11 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014893

Dose-dependent pharmacokinetics and psychomotor effects of caffeine in humans

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014893

Dose-dependency of caffeine metabolism with repeated dosing

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014893

Coffee consumption among psychiatric inpatients

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014893

Effects of caffeine withdrawal from the diet on the metabolism of clozapine in schizophrenic patients.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014893

Non-linear fluvoxamine disposition

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014893

Clozapine disposition covaries with CYP1A2 activity determined by a caffeine test

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014893

Caffeine and schizophrenia.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014893

Dose-dependent caffeine pharmacokinetics during severe sleep deprivation in humans.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014893

Fluvoxamine Inhibition and Carbamazepine Induction of the Metabolism of Clozapine

23 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1046%2FJ.1365-2125.2000.00111.X

The paraxanthine:caffeine ratio in serum or in saliva as a measure of CYP1A2 activity: when should the sample be obtained?

21 January 2018

1 reference

12 December 2020

Determination of clozapine and its major metabolites in human serum using automated solid-phase extraction and subsequent isocratic high-performance liquid chromatography with ultraviolet detection

1 reference

12 December 2020

Induction of hepatic CYP1A2 by the oral administration of caffeine to rats: lack of association with the Ah locus

1 reference

12 December 2020

Clozapine levels and caffeine

1 reference

12 December 2020

Caffeine induces cytochrome P4501A2: induction of CYP1A2 by tea in rats

1 reference

12 December 2020

Lack of correlation between fluvoxamine clearance and CYP1A2 activity as measured by systemic caffeine clearance

1 reference

12 December 2020

Absence of interaction between erythromycin and a single dose of clozapine

1 reference

12 December 2020

Disposition of caffeine and its metabolites in man

1 reference

12 December 2020

10.1046/J.1365-2125.2000.00111.X

Identifiers

DOI

1 reference

11 August 2017

1 reference

11 August 2017

1 reference